Clinical Trial Update: Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer [NA]

View source ↗

Summary

Feasibility trial evaluating intermittent fasting's impact on inflammation biomarkers and health-related quality of life in women with hormone receptor-positive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Breast Cancer | NA | Status: RECRUITING